• Molecular NameCiprofibrate
  • SynonymNA
  • Weight289.158
  • Drugbank_IDN/A
  • ACS_NO52214-84-3
  • Show 2D model
  • LogP (experiment)3.94
  • LogP (predicted, AB/LogP v2.0)3.62
  • pkaN/A
  • LogD (pH=7, predicted)0.63
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)0.06
  • LogSw (predicted, AB/LogsW2.0)0.02
  • Sw (mg/ml) (predicted, ACD/Labs)0.26
  • No.of HBond Donors1
  • No.of HBond Acceptors3
  • No.of Rotatable Bonds4
  • TPSA46.53
  • StatusN/A
  • AdministrationN/A
  • PharmacologyA fibrate.
  • Absorption_value99.0
  • Absorption (description)Ciprofibrate is readily absorbed after oral administration
  • Caco_2N/A
  • Bioavailability99.0
  • Protein binding95.0
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half life81 h in healthy individuals; 117 h (patients with mild renal failure; 154 h (patients undergoing haemodialysis); 172 h (severe renal failure)
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A